Literature DB >> 1943225

Cloning of the t(11;14)(q13;q32) translocation breakpoints from two human leukemia cell lines.

T C Meeker1, W Sellers, R Harvey, D Withers, K Carey, H Xiao, A M Block, B Dadey, T Han.   

Abstract

The t(11;14)(q13;q32) translocation has been associated with several subtypes of human leukemia and lymphoma. It has been proposed that this translocation activates a proto-oncogene designated BCL1. In an effort to better understand the mechanism by which this translocation leads to malignancy, we have studied this translocation in two human cell lines. MO1094 and MO2058 were derived from patients with prolymphocytic variants of chronic lymphocytic leukemia. Southern blotting of the MO2058 cell line documented that the translocation linked the Jh region in the immunoglobulin heavy chain gene to the previously described BCL1 major translocation cluster (MTC). Using the polymerase chain reaction, we cloned this translocation and showed that the chromosome 11 breakpoint was within 7 bp of two other samples reported previously. Southern blotting of the MO1094 cell line suggested that the translocation in this cell line might link Jh sequences to a new region in the BCL1 locus on chromosome 11. Therefore, the MO1094 breakpoint was cloned from a genomic library. Comparison with normal cloned DNA from the BCL1 locus showed that the chromosome 11 breakpoint occurred 24 kb telomeric of the MTC. This work reinforces the concept that translocation breakpoints in the BCL1 locus are scattered over at least 63 kb.

Entities:  

Mesh:

Year:  1991        PMID: 1943225

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma.

Authors:  Martina Rudelius; Stefania Pittaluga; Satoshi Nishizuka; Trinh H-T Pham; Falko Fend; Elaine S Jaffe; Leticia Quintanilla-Martinez; Mark Raffeld
Journal:  Blood       Date:  2006-04-27       Impact factor: 22.113

2.  A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.

Authors:  Christoph Renner; Pier Luigi Zinzani; Rémy Gressin; Dirk Klingbiel; Pierre-Yves Dietrich; Felicitas Hitz; Mario Bargetzi; Walter Mingrone; Giovanni Martinelli; Andreas Trojan; Krimo Bouabdallah; Andreas Lohri; Emmanuel Gyan; Christine Biaggi; Sergio Cogliatti; Francesco Bertoni; Michele Ghielmini; Peter Brauchli; Nicolas Ketterer
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

3.  Proteomic analysis of mantle-cell lymphoma by protein microarray.

Authors:  Irene M Ghobrial; Daniel J McCormick; Scott H Kaufmann; Alexey A Leontovich; David A Loegering; Nga T Dai; Kelly L Krajnik; Mary J Stenson; Mona F Melhem; Anne J Novak; Stephen M Ansell; Thomas E Witzig
Journal:  Blood       Date:  2005-01-13       Impact factor: 22.113

4.  Rapid high-resolution mapping of balanced chromosomal rearrangements on tiling CGH arrays.

Authors:  Harvey A Greisman; Noah G Hoffman; Hye Son Yi
Journal:  J Mol Diagn       Date:  2011-09-09       Impact factor: 5.568

5.  Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas.

Authors:  N S Aguilera; K E Bijwaard; B Duncan; A E Krafft; W S Chu; S L Abbondanzo; J H Lichy; J K Taubenberger
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

6.  IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas.

Authors:  Harvey A Greisman; Zhengfei Lu; Albert G Tsai; Timothy C Greiner; Hye Son Yi; Michael R Lieber
Journal:  Blood       Date:  2012-08-20       Impact factor: 22.113

7.  Cyclin alterations in diverse cancers: Outcome and co-amplification network.

Authors:  Maria Schwaederlé; Gregory A Daniels; David E Piccioni; Paul T Fanta; Richard B Schwab; Kelly A Shimabukuro; Barbara A Parker; Razelle Kurzrock
Journal:  Oncotarget       Date:  2015-02-20

8.  The positive nuclear staining observed with monoclonal antibody against PRAD1/cyclin D1 correlates with mRNA expression in mantle cell lymphoma.

Authors:  H Kuroda; H Komatsu; S Nakamura; Y Niitsu; T Takahashi; R Ueda; M Seto
Journal:  Jpn J Cancer Res       Date:  1995-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.